Deal Note: Crowell & Moring Client Integrated BioTherapeutics Enters Into Exclusive Agreement with Chembio Diagnostics to Develop POC Diagnostic Tests for Ebola
Firm News | less than 1 min read | 10.27.14
Washington, D.C. – October 27, 2014: Crowell & Moring, LLP is representing Integrated BioTherapeutics, Inc. (IBT), a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases, as it enters into an exclusive agreement with Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases. Under the terms of the agreement, Chembio will combine its patented DPP technology with IBT's proprietary Ebola reagents to develop POC diagnostic tests for Ebola and febrile illness. Chembio will have exclusive rights to any POC product developed through this agreement. Financial terms of the agreement were not disclosed.
Insights
Firm News | 1 min read | 07.18.25
OCLBA Honors Tiffany Chang with M. Katherine B. Darmer Outstanding Community Service Award
The Orange County Lavender Bar Association honored Crowell & Moring counsel Tiffany Chang with the M. Katherine B. Darmer Outstanding Community Service Award in recognition of her contributions to the community. The award was presented at the organization’s 15th anniversary celebration on July 16th.
Firm News | 4 min read | 07.17.25
Crowell & Moring Bolsters California Litigation Group with Two Former Amazon In-House Counsel
Firm News | 1 min read | 07.17.25
Firm News | 1 min read | 07.15.25
Crowell Advises MP Materials on Landmark Public-Private Partnership with Department of Defense